US Broker Ratings

Varex Imaging Corporation (VREX) Stock Analysis: A Healthcare Imaging Leader With Nearly 97% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX) stands as a notable player in the healthcare sector, particularly within the medical devices industry. The company, headquartered in Salt Lake City, Utah, specializes in..

TotalEnergies SE (TTE) Stock Analysis: A Strong Dividend Play with a 10.96% Upside Potential

TotalEnergies SE (TTE) stands as a formidable player in the global energy sector, offering a diverse portfolio that spans oil, biofuels, natural gas, and renewable energy solutions. With its roots..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 95% Potential Upside in the Medical Device Sector

Neuronetics, Inc. (NASDAQ: STIM), a key player in the medical device industry, is capturing investor attention with its innovative approach to treating neurohealth disorders and a striking potential upside of..

Gossamer Bio, Inc. (GOSS) Stock Report: Analysts See a Potential Upside of 459%—Is It Worth the Risk?

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company headquartered in San Diego, California, operates within the healthcare sector, focusing on groundbreaking treatments for pulmonary arterial hypertension (PAH). With a..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A Promising 261% Upside Potential with Robust Analyst Support

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of cancer immunotherapies. Headquartered in Needham, Massachusetts, Candel is dedicated..

XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotech Gem with 133% Potential Upside

As investors sift through the myriad opportunities in the healthcare sector, XOMA Royalty Corporation (NASDAQ: XOMA) stands out with a compelling growth narrative anchored by a remarkable potential upside of..

NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 67.95% Potential Upside in the Innovative Medical Imaging Sector

Nano-X Imaging Ltd (NASDAQ: NNOX) is capturing investor attention with its groundbreaking approach to medical imaging technology. Headquartered in Petah Tikva, Israel, this trailblazer in the healthcare sector is redefining..

National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a 2.86% Dividend Yield

National Research Corporation (NRC), a key player in the healthcare sector, specializes in providing analytics and insights designed to enhance the patient and employee experience. With a market capitalization of..

Exxon Mobil Corporation (XOM) Stock Analysis: Assessing a 9% Potential Upside

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to be a focal point for investors seeking stability and growth in the oil and gas industry. With..

Investor Outlook: Anbio Biotechnology (NNNN) – Navigating a Volatile Path in the Medical Instruments Sector

Anbio Biotechnology (NNNN), a burgeoning player in the medical instruments and supplies industry, is capturing attention with its rapid ascent in the stock market. Based in Frankfurt am Main, Germany,..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Unlocking a Potential 108% Upside with Strategic Healthcare Innovations

Alpha Teknova, Inc. (NASDAQ: TKNO), a prominent player in the healthcare sector specializing in the production of critical reagents, has caught the eye of investors with its substantial potential upside..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Potential 188.73% Upside Sparks Investor Interest

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology firm, is making waves in the healthcare sector with its innovative RNA medicines platform, PRISM. Despite its current financial challenges, the..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 37.74% Upside Potential in Healthcare Automation

Omnicell, Inc. (NASDAQ: OMCL), a key player in the Health Information Services industry, presents a fascinating opportunity for investors with its potential upside of 37.74%, according to analyst ratings. Operating..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating High Growth and Uncertainties in the Diagnostics Sector

GRAIL, Inc. (NASDAQ: GRAL) stands out in the healthcare sector with its ambitious mission to revolutionize cancer detection and diagnostics. As a commercial-stage company, GRAIL focuses on multi-cancer early detection..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Unlocking a 33.87% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, is generating buzz in the biotechnology sector with its promising product lineup and a potential upside of 33.87%. Specializing in therapies..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating a 33% Potential Upside with Healthcare Savings Innovation

GoodRx Holdings, Inc. (NASDAQ: GDRX) continues to draw investor attention with its innovative approach in the healthcare sector, specifically within health information services. The company, headquartered in Santa Monica, California,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating a 27% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD) presents an intriguing proposition for investors within the healthcare sector, offering a mix of challenges and potential opportunities. As a key player in the..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 98% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a key player in the healthcare sector, is quickly gaining traction among investors due to its impressive revenue growth and significant potential upside. As a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring an 86% Upside Potential in Biotechnology

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a pioneering biopharmaceutical company specializing in innovative therapies for eye conditions, has drawn considerable interest from investors due to its robust growth potential and a..

Innoviva, Inc. (INVA) Stock Analysis: A Deep Dive into Its 190.85% Potential Upside

Innoviva, Inc. (NASDAQ: INVA) is making waves in the biotechnology sector with its impressive potential upside of 190.85%, according to recent analyst ratings. As a player in the healthcare industry,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds